Xycrobe Therapeutics Overview
- Founded
- 2014
- Status
- Acquired/Merged
- Employees
- 3
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 3
Xycrobe Therapeutics General Information
Description
Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to address the needs of patients with inflammatory skin disease.
Contact Information
Primary Industry
Biotechnology
Acquirer
Primary Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Xycrobe Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Xycrobe Therapeutics‘s full profile, request access.
Request a free trialXycrobe Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Hitchcock Ph.D | Founder, Chief Executive Officer and Board Member |
Xycrobe Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialXycrobe Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Xycrobe Therapeutics‘s full profile, request access.
Request a free trial